id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-325408-uy5ew3ki	Singer, Benjamin D.	A Call for Rational Intensive Care in the Era of COVID-19	2020-07-17		.txt	text/plain	1609	91	48	As intensive care physicians, we have been trained to treat viral pneumonia and its attendant complications of acute respiratory distress syndrome (ARDS) and multiorgan failure. In fact, the patients enrolled in the ARMA (Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress) trial of low-tidal-volume ventilation and the PROSEVA (Proning Severe ARDS Patients) trial of prone positioning exhibited myriad etiologies, compliances, and shunt fractions but nevertheless benefited from the targeted interventions (4, 5) . Currently, numerous agents are being administered to patients with COVID-19 outside of controlled trials, including hydroxychloroquine, azithromycin, doxycycline, remdesivir, lopinavir-ritonavir, heparin, low-molecular-weight heparin, tissue plasminogen activator, glucocorticoids, tocilizumab, eculizumab, IFN-b, IFN-g, IL-1 inhibitors, mesenchymal stem cells, convalescent plasma, nitric oxide, vitamin C, and others. We show in the present study that severe RSV infection in infants is associated with a marked upregulation of CD32 on T cells.	./cache/cord-325408-uy5ew3ki.txt	./txt/cord-325408-uy5ew3ki.txt